USANA Health Sciences – Aggressive Growth

Email

USANA Health Sciences Inc. (USNA) raised its outlook for the full year during its third-quarter report, which also saw this nutrition and personal care products company beat earnings estimates for the seventh straight quarter. With a year-to-date return of roughly 36.3% and a long-term expected earnings growth rate of 18.0%, this Zacks #1 Rank (Strong Buy) looks like a solid growth pick.

Solid Third Quarter Results

On Oct 23, USANA Health Sciences announced that third-quarter earnings of $1.18 per share topped the Zacks Consensus Estimate by 11.3% and last year’s performance by 45.7%. The year-over-year improvement was led by higher sales, lower associate incentive expense and a lower effective tax rate.

Revenues increased 15.1% year over year to $165.2 million, driven by strong performances in Asia Pacific, North America and Europe.

Upbeat Guidance

Based on the strong third quarter results, USANA Health Sciences raised its outlook for 2012. Net sales are now expected to reach $645 million, up from the previous range of $630 million to $640 million.

The company also raised its 2012 earnings guidance to between $4.35 and $4.40 per share from the previous range of $4.10 to $4.20. USANA Health Sciences expects the strong performance to continue due to the Lifetime Matching Bonus and other initiatives.

Earnings Estimates on the Rise

The Zacks Consensus Estimate for 2012 rose 4.5% to $4.39 per share in the last 60 days, as all 5 estimates were revised upward. This represents a year-over-year increase of 34.6%.

The Zacks Consensus Estimate for 2013 grew 4.8% to $4.84 per share over the same time frame as all 5 estimates again were raised. This reflects a year-over-year increase of 10.4%.

Attractive Valuation

USANA Health Sciences is currently trading at a forward price-to-earnings (P/E) of 9.8x, a 23.4% discount to the peer group average of 12.8x. Its P/S ratio of 1.0 is well below its peer group average of 3.2. Moreover, the company’s return on equity (ROE) is 32.8%, above the peer group average of 29.6%.

The year-to-date return for the stock is 36.3%. Volume is quite strong, averaging roughly 228K daily.

USANA Health Sciences is focused on the development and manufacturing of nutritionals and personal care products. The company, which sells its products through a global network marketing system, operates primarily in two geographic regions: North America/Europe and Asia Pacific. Primary product lines at USANA Health consist of USANA Nutritionals (Essentials and Optimizers), USANA Foods, and Sensé. Founded in 1992, the company has a market cap of $620.1 million and competes with Mannatech Inc. (MTEX).


Want More of Our Best Recommendations?

Zacks' Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Then each week he hand-selects the most compelling trades and serves them up to you in a new program called Zacks Confidential.

Learn More>>




 
USANA HLTH SCI (USNA): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Join the conversation. Click here to jump to comments…

Leave a Reply

Your email address will not be published. Required fields are marked *


6 + four =

Some HTML is OK

© 2014 Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201, Email: customerservice@MoneyMorning.com